검색어 : 통합검색[Hwang David Henry]
총 189건 중 189건 출력
, 19/19 페이지
-
181
-
Catheter ablation for patients with mappable versus unmappable VT late after myocardial infarction
-
Wilber, David J.;
Stevenson, William G.;
Nakagawa, Hiroshi;
Natale, Andrea;
Marchlinski, Francis E.;
Schuger, Claudio;
Hwang, Chun;
Daoud, Emile G.;
;
(Heart rhythm,
v.2,
2005,
pp.S119-S119)
-
182
-
Rapid 3D bioprinting of a multicellular model recapitulating pterygium microenvironment
-
Zhong, Zheng;
Wang, Jing;
Tian, Jing;
Deng, Xiaoqian;
Balayan, Alis;
Sun, Yazhi;
Xiang, Yi;
Guan, Jiaao;
Schimelman, Jacob;
Hwang, Henry;
You, Shangting;
Wu, Xiaokang;
Ma, Chao;
Shi, Xiaoao;
Yao, Emmie;
Deng, Sophie X.;
Chen, Shaochen;
Department of NanoEngineering, University of California San Diego;
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles;
Department of NanoEngineering, University of California San Diego;
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles;
Department of NanoEngineering, University of California San Diego;
Department of NanoEngineering, University of California San Diego;
Department of NanoEngineering, University of California San Diego;
Department of NanoEngineering, University of California San Diego;
Department of NanoEngineering, University of California San Diego;
Department of NanoEngineering, University of California San Diego;
Department of NanoEngi;
(Biomaterials,
v.282,
2022,
pp.121391)
-
183
-
Pedicle Screw-Associated Violation of the Adjacent Unfused Facet Joint: Clinical Outcomes and Fusion Rates
-
Sinz, Nathan J.;
Hwang, Raymond W.;
Lee, Gyu-Ho;
Baker, Kevin C.;
Arnold, Paul;
Sasso, Rick;
Park, Daniel;
Fischgrund, Jeffrey;
Niu, Ruijia;
Kim, David H.;
Department of Orthopaedic Surgery, Tufts Medical Center, Boston, MA, USA;
Department of Orthopaedic Surgery, Tufts Medical Center, Boston, MA, USA;
Icahn School of Medicine at Mount Sinai, New York, NY, USA;
Bone & Joint Center, Dept. of Orthopaedic Surgery, Henry Ford Health System, Detroit, MI, USA;
Carle Neuroscience Institute, Urbana, IL, USA;
Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IL, USA;
Department of Orthopaedic Surgery, William Beaumont Hospital, Royal Oak, MI, USA;
Department of Orthopaedic Surgery, William Beaumont Hospital, Royal Oak, MI, USA;
Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA;
Department of Orthopaedic Surgery, Tufts Medical Center, Boston, MA, USA;
(Global spine journal,
v.14,
2024,
pp.1477-1484)
-
184
-
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
-
Fu, Julie;
Reid, Sonya A.;
French, Benjamin;
Hennessy, Cassandra;
Hwang, Clara;
Gatson, Na Tosha;
Duma, Narjust;
Mishra, Sanjay;
Nguyen, Ryan;
Hawley, Jessica E.;
Singh, Sunny R. K.;
Chism, David D.;
Venepalli, Neeta K.;
Warner, Jeremy L.;
Choueiri, Toni K.;
Schmidt, Andrew L.;
Fecher, Leslie A.;
Girard, Jennifer E.;
Bilen, Mehmet A.;
Ravindranathan, Deepak;
Goyal, Sharad;
Wise-Draper, Trisha M.;
Park, Cathleen;
Painter, Corrie A.;
McGlown, Sheila M.;
de Lima Lopes Jr, Gilberto;
Serrano, Oscar K.;
Shah, Dimpy P.;
Department of Internal Medicine, Hematology-Oncology, Tufts Medical Center Cancer Center, Stoneham, Massachusetts;
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee;
Department of Biostatistics, Vanderbilt University, Nashville, Tennessee;
Department of Biostatistics, Vanderbilt University, Nashville, Tennessee;
Department of Internal Medicine, Division of Hematology-Oncology, Henry Ford Cancer Institute, Detroit, Michigan;
Geisinger Health System, Danville, Danville, Pennsylvania;
Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts;
Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, Tennessee;
Department of Hematology and Oncology, University of Illinois, Chicago;
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York;
Department of Internal Medicine, Division of Hematology-Oncology, Henry Ford Cancer Institu;
(Jama network open,
v.5,
2022,
pp.e224304)
-
185
-
A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16+ cancers.
-
Burman, Bharat;
Niu, Jiaxin;
Leidner, Rom S.;
Wang, Ding;
Richardson, Debra L.;
Iacobucci, Corinne;
Hwang, Andy;
Qing, Xiaoping;
Matushansky, Igor;
Zamarin, Dmitriy;
Ho, Alan Loh;
Pfister, David G.;
Posner, Marshall R.;
Memorial Sloan Kettering Cancer Center, New York, NY;
;
Banner MD Anderson Cancer Center, Gilbert, AZ;
;
Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR;
;
Henry Ford Hospital, Detroit, MI;
;
Stephenson Cancer Center University of Oklahoma Health Sciences Center and Sarah Cannon Research Institute, Oklahoma City, OK;
;
Hookipa Pharma, New York, NY;
;
Hookipa Pharma, New York, NY;
;
Hookipa Pharma, New York, NY;
;
Hookipa Pharma, New York, NY;
;
Memorial Sloan Kettering Cancer Center, New York, NY;
;
Memorial Sloan Kettering Cancer Center, New York, NY;
;
Memorial Sloan Kettering Cancer Center, New York, NY;
;
Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.38,
2020,
pp.TPS3171-TPS3171)
-
186
-
Post-acute sequelae of SARS-CoV-2 infection in patients with cancer.
-
Warner, Jeremy Lyle;
Pinato, David J. James;
Mishra, Sanjay;
Saliby, Renee Maria;
Hwang, Clara;
Gulati, Shuchi;
McKay, Rana R.;
Labaki, Chris;
Griffiths, Elizabeth A.;
Jani, Chinmay;
Yu, Peter Paul;
Portuguese, Andrew Jay;
Puc, Matthew;
Egan, Pamela;
Shah, Sumit;
Kasi, Anup;
Berg, Stephanie A.;
Flora, Daniel Blake;
Accordino, Melissa Kate;
Shah, Dimpy P;
Vanderbilt-Ingram Cancer Center, Nashville, TN;
;
Department of Surgery and Cancer, Imperial College, London, United Kingdom;
;
Vanderbilt University Medical Center, Nashville, TN;
;
Dana-Farber Cancer Institute, Boston, MA;
;
Henry Ford Health System, Detroit, MI;
;
University of Cincinnati College of Medicine, Cincinnati, OH;
;
University of California San Diego Health, La Jolla, CA;
;
Dana Farber Cancer Institute, Boston, MA;
;
Roswell Park Cancer Institute, Buffalo, NY;
;
Mount Auburn Hospital, Cambridge, MA;
;
Hartford HealthCare Cancer Institute, Hartford, CT;
;
University of Washington, Seattle, WA;
;
Virtua Health, Marlton, NJ;
;
Rhode Island Hospital, Providence, RI;
;
Stanford Cancer Institute, Stanford, CA;
;
University of Kansas Cancer Center, Westwood, KS;
;
Loyola University Medical Center, Maywood, IL;
;
Univ Hosp/Univ of Cincinnati, Cincinnati, OH;
;
Columbia University, New York, NY;
;
University of Texas Health Science Center San Antonio, San Antonio, TX;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.40,
2022,
pp.e18746-e18746)
-
187
-
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
-
Hawley, Jessica E.;
Sun, Tianyi;
Chism, David D.;
Duma, Narjust;
Fu, Julie C.;
Gatson, Na Tosha N.;
Mishra, Sanjay;
Nguyen, Ryan H.;
Reid, Sonya A.;
Serrano, Oscar K.;
Singh, Sunny R. K.;
Venepalli, Neeta K.;
Bakouny, Ziad;
Bashir, Babar;
Bilen, Mehmet A.;
Caimi, Paolo F.;
Choueiri, Toni K.;
Dawsey, Scott J.;
Fecher, Leslie A.;
Flora, Daniel B.;
Friese, Christopher R.;
Glover, Michael J.;
Gonzalez, Cyndi J.;
Goyal, Sharad;
Halfdanarson, Thorvardur R.;
Hershman, Dawn L.;
Khan, Hina;
Labaki, Chris;
Lewis, Mark A.;
McKay, Rana R.;
Messing, Ian;
Pennell, Nathan A.;
Puc, Matthew;
Ravindranathan, Deepak;
Rhodes, Terence D.;
Rivera, Andrea V.;
Roller, John;
Schwartz, Gary K.;
Shah, Sumit A.;
Shaya, Justin A.;
Streckfuss, Mitrianna;
Thompson, Michael A.;
Wulff-Burchfield, Elizabeth M.;
Xie, Zhuoer;
Yu, Peter Paul;
Warner, Jeremy L.;
Shah, Dimpy P.;
French, Benjamin;
Hwang, Clara;
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York;
Vanderbilt University Medical Center, Nashville, Tennessee;
Thompson Cancer Survival Center, Knoxville, Tennessee;
University of Wisconsin Carbone Cancer Center, Madison;
Tufts Medical Center Cancer Center, Boston and Stoneham, Massachusetts;
Geisinger Health System, Danville, Pennsylvania;
Vanderbilt University Medical Center, Nashville, Tennessee;
University of Illinois Hospital & Health Sciences System, Chicago;
Vanderbilt University Medical Center, Nashville, Tennessee;
Hartford HealthCare Cancer Institute, Hartford, Connecticut;
Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan;
University of North Carolina, Lineberger Cancer Center, Chapel Hill;
Dana-Farber Cancer Institute, Boston, Massachusetts;
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania;
Winship Cancer Institute of Emory University, Atlanta, Georgia;
Case Comprehens;
(Jama network open,
v.5,
2022,
pp.e2142046)
-
188
-
<i>KRAS</i> Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer
-
Burgess, Michael R.;
Hwang, Eugene;
Mroue, Rana;
Bielski, Craig M.;
Wandler, Anica M.;
Huang, Benjamin J.;
Firestone, Ari J.;
Young, Amy;
Lacap, Jennifer A.;
Crocker, Lisa;
Asthana, Saurabh;
Davis, Elizabeth M.;
Xu, Jin;
Akagi, Keiko;
Le Beau, Michelle M.;
Li, Qing;
Haley, Benjamin;
Stokoe, David;
Sampath, Deepak;
Taylor, Barry S.;
Evangelista, Marie;
Shannon, Kevin;
Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA;
Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA;
Department of Discovery Oncology, Genentech, South San Francisco, CA 94080, USA;
Marie-José
e and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA;
Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA;
Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA;
Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA;
Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA;
Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA;
Department of Translational Oncology, Genentech, South San Francisco, CA 94080, USA;
Department of Medicine, University of Cal;
(Cell,
v.168,
2017,
pp.817-829.e15)
-
189
-
First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers.
-
Ho, Alan Loh;
Posner, Marshall R.;
Niu, Jiaxin;
Fu, Siqing;
Leidner, Rom S.;
Pearson, Alexander T.;
Chung, Ki Y.;
Richardson, Debra L.;
Wang, Ding;
Pimentel, Agustin;
Nieva, Jorge J.;
Rosenberg, Ari;
Burman, Bharat;
Iacobucci, Corinne;
Qing, Xiaoping;
Hwang, Andy;
Katchar, Kia;
Schlienger, Katia;
Matushansky, Igor;
Pfister, David G.;
Memorial Sloan Kettering Cancer Center, New York, NY;
;
Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY;
;
Banner MD Anderson Cancer Center, Gilbert, AZ;
;
The University of Texas MD Anderson Cancer Center, Houston, TX;
;
Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR;
;
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL;
;
Institute for Translational Oncology Research, Prisma Health-Upstate Cancer Institute, Greenville, SC;
;
Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK;
;
Henry Ford Hospital, Detroit, MI;
;
University of Miami Sylvester Comprehensive Cancer Center, Miami, FL;
;
University of Southern California, Los Angeles, CA;
;
University of Chicago, Chicago, IL;
;
Memorial Sloan Kettering Cancer Center, New York, NY;
;
Hookipa Pharma Inc., New York, NY;
;
Hookipa Pharma Inc., New York, NY;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.39,
2021,
pp.2502-2502)